2,6-Bis[(2-Hydroxyethyl)Amino]Toluene | CAS:149330-25-6

We serve 2,6-Bis[(2-Hydroxyethyl)Amino]Toluene CAS:149330-25-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2,6-Bis[(2-Hydroxyethyl)Amino]Toluene

Chemical Name:2,6-Bis[(2-Hydroxyethyl)Amino]Toluene
CAS.NO:149330-25-6
Synonyms:2-[3-(2-hydroxyethylamino)-2-methylanilino]ethanol; 2,6-Bis[(2-hydroxyethyl)amino]toluene;
Molecular Formula:C11H18N2O2
Molecular Weight:210.27300
 
Physical and Chemical Properties:
Density:1.217;
Melting point:116-120oC;
Boiling point:463.454oC;
Flash point:206.232oC;
Index of Refraction:1.646;
 
Specification:
Appearance:Off-white powder
Purity:≥99.0%
Ash:≤0.5%
Loss on drying:≤0.5%
Fe content:≤100ppm
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Hair dyes intermediate



Contact us for information like 2,6-Bis[(2-Hydroxyethyl)Amino]Toluene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-[3-(2-hydroxyethylamino)-2-methylanilino]ethanol 2,6-Bis[(2-hydroxyethyl)amino]toluene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,6-Bis[(2-Hydroxyethyl)Amino]Toluene Use and application,2,6-Bis[(2-Hydroxyethyl)Amino]Toluene technical grade,usp/ep/jp grade.


Related News: The safety and effectiveness of TCM is still debated in China, where it has both adherents and skeptics.2,6-dichlorobenzenethiol manufacturer The South Korean government is banning entry to all foreign nationals who visited China’s Hubei province in the past 14 days.2,3,5-三甲基吡嗪 supplier The novel coronavirus has resulted in thousands of confirmed human infections in more than 20 countries, with more than 99 percent of cases in China.1-(3-Amino-2-hydroxyphenyl)ethanone vendor The novel coronavirus has resulted in thousands of confirmed human infections in more than 20 countries, with more than 99 percent of cases in China.As proof-of-principle for the unique advantages arising from selecting a single engineered iPSC clone for the production of CAR T-cell therapy, the scientists assessed 747 clones after engineering a pool of cells using CRISPR. It was found that only about 2% of clones met the Company’s standards for overall quality including containing both bi-allelic disruption of the TCR, proper insertion of the CAR into the TRAC locus without random transgene integrations, and no evidence of off-target genomic modifications or translocations.